Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/1998
09/29/1998CA2043033C Use of baclofen to obtain medication for the treatment of angina
09/29/1998CA2020474C Antiinflammatory and/or antiallergic composition
09/28/1998CA2233377A1 Nk-1 receptor antagonists for the treatment of delayed emesis
09/27/1998CA2232499A1 Benzyloxy-substituted, fused n heterocycles, process for their preparation, and their use as bradykinin reception antagonists
09/25/1998CA2233077A1 Pharmaceutical compounds
09/25/1998CA2232930A1 Oral application of (+)-o-demethyltramadol as a pain killing drug
09/24/1998WO1998041631A2 β-CATENIN, TCF-4, AND APC INTERACT TO PREVENT CANCER
09/24/1998WO1998041617A1 Stimulation, culture and preservation of pancreatic and other cells
09/24/1998WO1998041562A1 Non-antigenic branched polymer conjugates
09/24/1998WO1998041528A1 Substituted 4-arylmethylene-2-imino-2,3-dihydrothiazoles and derivatives and their pharmaceutical use
09/24/1998WO1998041527A1 Pyrroloazepine compounds
09/24/1998WO1998041525A1 Pyrrolo[2,3d]pyrimidines and their use as tyrosine kinase inhibitors
09/24/1998WO1998041519A1 Novel cannabinoid receptor agonists
09/24/1998WO1998041516A1 (methylsulfonyl)phenyl-2-(5h)-furanones with oxygen link as cox-2 inhibitors
09/24/1998WO1998041512A1 Substituted 2-anilinopyrimidines useful as protein kinase inhibitors
09/24/1998WO1998041511A1 Pyridazinones as inhibitors of cyclooxygenase-2
09/24/1998WO1998041509A1 Methods and compositions for treating polycystic ovary syndrome
09/24/1998WO1998041508A1 Substituted isoquinoline derivatives and their use as anticonvulsants
09/24/1998WO1998041507A1 Anti-convulsant isoquinolyl-benzamide derivatives
09/24/1998WO1998041506A1 Novel quinoline- and naphthalenecarboxamides, pharmaceutical compositions and methods of inhibiting calpain
09/24/1998WO1998041505A1 Method for producing particles of pyrithione salts
09/24/1998WO1998041501A1 2-alkylidene-19-nor-vitamin d compounds
09/24/1998WO1998041500A1 2-alkyl-19-nor-vitamin d compounds
09/24/1998WO1998041238A2 Methods and kits for treating and diagnosing leiomyomas
09/24/1998WO1998041236A1 Pharmaceutical composition for eliminating membrane-mediated cell resistance
09/24/1998WO1998041232A2 Compositions for modulating responsiveness to corticosteroids
09/24/1998WO1998041231A1 Suppression of malignancy utilizing ribonucleotide reductase r1
09/24/1998WO1998041226A1 Pharmaceutical combined preparations containing erythropoietin and iron preparations
09/24/1998WO1998041223A1 N-methyl-d-aspartate receptor channel blockers and method for identifying such
09/24/1998WO1998041217A1 Therapeutic combination of mineral and vitamin in units of liquid preparation for oral administration
09/24/1998WO1998041216A1 Composition for prevention of hepatic steatosis
09/24/1998WO1998041214A1 Remedies for ischemic reflow disturbances
09/24/1998WO1998041213A1 Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
09/24/1998WO1998041212A1 New formulation
09/24/1998WO1998041211A1 Methods and compositions for treating polycystic ovary syndrome
09/24/1998WO1998041210A1 Sustained-release prostaglandin i derivative preparation
09/24/1998WO1998041209A1 Protective agents for cells constituting nervous system
09/24/1998WO1998041208A1 Compositions and methods for reducing ocular hypertension
09/24/1998WO1998041207A1 Administration of an injectable antibiotic in the ear of an animal
09/24/1998WO1998041206A1 Novel carboxylic acid derivatives, their preparation and use in treating cancer
09/24/1998WO1998041205A1 Cytochalasin and isoindolinone derivatives as inhibitors of angiogenesis
09/24/1998WO1998041204A1 Ascorbic acid as an adjuvant in the treatment of malignant tumors using chemo- and radiotherapy
09/24/1998WO1998041203A1 Ascorbic acid as an adjuvant in the removal of vascular occlusions
09/24/1998WO1998041202A1 Hydroxybenzoate metabolites and hydroxybenzoate analogues as protectors against oxidative stress and chemotherapeutic drug cytotoxicity, cardiotoxicity and extravasation tissue injury
09/24/1998WO1998041201A1 Therapeutic compositions
09/24/1998WO1998041200A1 Therapeutic compositions
09/24/1998WO1998041199A1 Decongestant for nose or eye
09/24/1998WO1998041198A1 Method of inhibiting fibrosis with pyridoxal benzoyl hydrazone and analogs thereof
09/24/1998WO1998041197A1 METHOD FOR TREATMENT OF $i(H. PYLORI)
09/24/1998WO1998041196A1 Antiviral agents
09/24/1998WO1998041193A1 Preparation of powder agglomerates
09/24/1998WO1998041191A1 Aerosol preparation
09/24/1998WO1998041171A1 Controlled release of pharmaceuticals in the anterior chamber of the eye
09/24/1998WO1998041092A1 Novel indolecarboxamides, pharmaceutical compositions and methodsof inhibiting calpain
09/24/1998DE19713434C1 Protein zur Inhibierung von Apoptose Protein for the inhibition of apoptosis
09/24/1998DE19711800A1 Verlängerung der Expression von transgenen Proteinen durch immunmodulierende Behandlung Extension of the expression of transgenic proteins by modifying treatments
09/24/1998DE19711616A1 Verbessertes Verfahren zur Herstellung von Thiazolidindionen An improved process for the preparation of thiazolidinediones
09/24/1998CA2644454A1 Death domain containing receptor 5
09/24/1998CA2285988A1 Antiviral agents
09/24/1998CA2285701A1 .beta.-catenin, tcf-4, and apc interact to prevent cancer
09/24/1998CA2284218A1 Substituted isoquinoline derivatives and their use as anticonvulsants
09/24/1998CA2284039A1 Methods and kits for treating and diagnosing leiomyomas
09/24/1998CA2284035A1 Novel quinoline- and naphthalenecarboxamides, pharmaceutical compositions and methods of inhibiting calpain
09/24/1998CA2283961A1 Pyrrolo[2,3d]pyrimidines and their use as tyrosine kinase inhibitors
09/24/1998CA2283882A1 Method for producing particles of pyrithione salts
09/24/1998CA2283797A1 Novel cannabinoid receptor agonists
09/24/1998CA2283738A1 Ascorbic acid as an adjuvant in the removal of vascular occlusions
09/24/1998CA2283732A1 Novel carboxylic acid derivatives, their preparation and use in treating cancer
09/24/1998CA2283691A1 Therapeutic combination of mineral and vitamin in units of liquid preparation for oral administration
09/24/1998CA2283682A1 Anti-convulsant isoquinolyl-benzamide derivatives
09/24/1998CA2283438A1 Substituted 4-arylmethylene-2-imino-2,3-dihydrothiazoles and derivatives and their pharmaceutical use
09/24/1998CA2283297A1 New formulation
09/24/1998CA2283100A1 (methylsulfonyl)phenyl-2-(5h)-furanones with oxygen link as cox-2 inhibitors
09/24/1998CA2283098A1 Methods and compositions for treating polycystic ovary syndrome
09/24/1998CA2282845A1 Methods and compositions for modulating responsiveness to corticosteroids
09/24/1998CA2255024A1 Protective agents for cells constituting nervous system
09/24/1998CA2254875A1 Pyrroloazepine compounds
09/23/1998EP0866124A2 Composition containing a compound modifying directly or indirectly the activity of endogenous T1-M protein
09/23/1998EP0866063A1 10, 11-Methanodibenzosuberane derivatives used as chemosensitizing agents
09/23/1998EP0865790A2 Use of triazolopyridazine derivatives in the manufacture of a medicament for the treatment of atopic dermatitis
09/23/1998EP0865789A2 Pharmaceutical compositions for intranasal administration of dihydroergotamine
09/23/1998EP0865788A1 Specific cyclooxygenase 2 inhibitor and anti-inflammatory agent
09/23/1998EP0865609A1 Method of diagnosing and treating epithelioma
09/23/1998EP0865492A1 Specific binding members for human carcinoembryonic antigen, materials and methods
09/23/1998EP0865491A1 Compounds having lectin properties and biological uses thereof
09/23/1998EP0865489A1 Modified vegf antisense oligonucleotides
09/23/1998EP0865447A1 Cyclic dodecapeptide and process for the preparation thereof
09/23/1998EP0865446A1 Agents for promoting bone formation
09/23/1998EP0865445A1 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties
09/23/1998EP0865440A1 Farnesyl protein transferase inhibiting (imidazol-5-yl)methyl-2-quinolinone derivatives
09/23/1998EP0865439A1 Combinatorial libraries having aminodiol monomer subunits
09/23/1998EP0865431A2 Compounds
09/23/1998EP0865430A1 3-(4-subst.-piperidinyl-1)-1-(3,4-dichlorophenyl)propyl carbamates and ureas and derivatives as novel neurokinin antagonists
09/23/1998EP0865429A1 Azetidinone compounds for the treatment of atherosclerosis
09/23/1998EP0865428A1 Vitamin d analogues
09/23/1998EP0865427A1 Synthesis of 1alpha-hydroxy vitamin d
09/23/1998EP0865426A1 Amino acid derivatives, medicaments containing said compounds and methods of producing said compounds
09/23/1998EP0865425A1 Amino acid derivatives, medicaments containing said compounds and methods of producing them
09/23/1998EP0865422A1 Amino alcohol derivatives, methods of producing said derivatives and medicaments containing them
09/23/1998EP0865421A1 Arylethanolamine derivatives and their use as agonists of atypical beta-adrenoceptors